Treatment of infections in patients with the acquired immunodeficiency syndrome.
about
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophagesAmikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige miceEnhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige miceBroth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndromeIn vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosisTreatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacinHigh-dose intravenous immunoglobulin and splenectomy for the treatment of HIV-related immune thrombocytopenia in patients with severe haemophilia.Gastrointestinal manifestations of the acquired immunodeficiency syndrome.Candida and oral candidosis: a review.In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism.Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates.Acyclovir prophylaxis for herpes simplex virus infection.Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome.Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.Immunosuppression and mycobacteria other than Mycobacterium tuberculosis: results from patients with and without HIV infectionMycobacterial infection in patients infected with the human immunodeficiency virus.CMV oophoritis in an AIDS patient.Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.The Mycobacterium avium complexEfficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.Association between HIV distal symmetric polyneuropathy and Mycobacterium avium complex infection.In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice.Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic toolClinical and epidemiological importance of typing of Mycobacterium avium complex isolates.Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction.Serovars of Mycobacterium avium complex isolated from patients in Sweden.Prevalence of serum antibody to the type-specific glycopeptidolipid antigens of Mycobacterium avium in human immunodeficiency virus-positive and -negative individualsDisseminated Pneumocystis carinii in a patient receiving aerosolized pentamidine prophylaxisPneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants.Comparison of large restriction fragments of Mycobacterium avium isolates recovered from AIDS and non-AIDS patients with those of isolates from potable water.Life-threatening opportunistic fungal infection in patients with the acquired immunodeficiency syndrome.AIDS-related mycobacterial disease.Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents.Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.Interaction between fluconazole and rifampicin.The Voltage-Dependent Anion Channels (VDAC) of Mycobacterium avium phagosome are associated with bacterial survival and lipid export in macrophages.Identification of a beta 1 integrin on Mycobacterium avium-Mycobacterium intracellulare.Rapid detection and identification of Mycobacterium avium by amplification of 16S rRNA sequences.
P2860
Q28330701-5541F9FD-E02B-4599-8EF6-8BCBCE84995AQ28356424-F315784B-5A20-42B0-B4C6-331DB1130663Q28361166-07125E3C-A649-49C7-85C3-39820D87E6A8Q28361676-4872C273-82C3-4E77-B018-38858288A578Q28369524-C45418E0-9C81-4DFA-B587-187450A09FADQ28379298-18546485-7EC0-44FF-8DA1-C12620EE57DEQ33449059-5CA11EF2-CDA6-4027-B18A-85B9B96FA676Q34195088-DF13F94E-E3CA-4D96-A235-F395C0F07DFDQ34318789-14D3E5AF-94B2-415A-82E3-0560C829276AQ34534366-ECC88AA1-AD12-4D0A-B959-5016278C8D0DQ35264265-3FF16E8B-321F-4EDA-BAF3-402058231D4AQ35537506-1DD1DE25-D399-479A-9A7C-BB3C39B9909EQ35584555-CC02E613-2573-40B3-940B-1CEDADF0A3FCQ35654015-A65C795E-0B75-4E24-8F22-EEA0DDF18479Q35836636-111FC5CE-9822-4728-9696-225FDD28C31AQ36225746-2482571D-5DC8-4316-BE59-26A9D5058BB2Q36473342-FC225497-B1E9-4904-9500-6EE0523E4D1FQ36587951-DB907053-9EA8-48FC-BE03-9E15FAE360CCQ36629153-4640D201-00DF-4AA6-B862-DF0D7E5508F3Q36635613-E21F21B7-6220-46C7-BB1B-0B03F89E63F4Q36640345-45A270D2-14E8-44BC-A9A0-9FB52558721EQ36758404-8CD365B8-5882-4F61-87AA-B3A53E625D79Q36900008-F7E1F076-EFD6-4EE7-9581-866BCAB9C63CQ36967404-EF81EEF0-0F64-4D93-8241-F661FF781922Q37064380-3E887660-332C-4305-BC12-048B658E1852Q37116379-802B01A2-FDCB-4506-89F0-C610041FA58BQ37178327-99D268C6-44EF-4EC6-B9A2-CF8F11E9013EQ37183713-DAEDCD5F-064A-48E1-A831-D7626E629C58Q37234741-56E61340-1E4F-4324-8CC4-A683F82176DBQ37948745-3BEF4775-863B-48B8-A6A3-9F1D271D7D17Q39103169-79775944-D53E-4A6A-896A-3050B4C424CEQ39467765-236FEA2E-2370-41CF-98EA-CE285E0CB867Q39554288-F9171C01-E8BF-4915-A5DF-EE1BECEB9CCBQ39559390-5E2963B8-F174-4D70-8E97-2B018630A5DBQ39827520-8DB0129E-D9B6-4BE3-981A-604F983E3B43Q39832318-7899E0EC-C2E2-4E28-A7BF-0AC9EAD6D802Q39945776-6A6360FC-8F43-4B6A-9178-AD4B2980551DQ40110531-B2E04649-2634-4243-8A56-2A22A1CCB3E5Q40147865-2048A2F2-B60E-4602-B79C-A33E342FD962Q40188891-EA47E23A-73AD-4D5C-9C0A-2F4E95F3A88A
P2860
Treatment of infections in patients with the acquired immunodeficiency syndrome.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Treatment of infections in patients with the acquired immunodeficiency syndrome.
@en
Treatment of infections in patients with the acquired immunodeficiency syndrome.
@nl
type
label
Treatment of infections in patients with the acquired immunodeficiency syndrome.
@en
Treatment of infections in patients with the acquired immunodeficiency syndrome.
@nl
prefLabel
Treatment of infections in patients with the acquired immunodeficiency syndrome.
@en
Treatment of infections in patients with the acquired immunodeficiency syndrome.
@nl
P2093
P1476
Treatment of infections in patients with the acquired immunodeficiency syndrome.
@en
P2093
Armstrong D
Dryjanski J
P304
P356
10.7326/0003-4819-103-5-738
P407
P577
1985-11-01T00:00:00Z